Top Abstract Purchase Related
Home
>
Node
>
Subnode

Suppressive effect of IgA soluble immune complexes on neutrophil chemotaxis

Ito, S.; Mikawa, H.; Shinomiya, K.; Yoshida, T.

Clinical and Experimental Immunology 37(3): 436-440

1979

ISSN/ISBN: 0009-9104
PMID: 116785
Document Number: 139437
The effect of IgA and IgG soluble immune complexes (SIC) on neutrophil chemotaxis was investigated. Six types of SIC were prepared from kappa-type IgA and IgG myeloma proteins: IgA-anti-kappa chain antibody SIC in IgA excess, IgA-anti-kappa chain antibody in SIC in anti-kappa chain antibody excess, IgA-anti-alpha chain antibody SIC in IgA excess, IgG-anti-kappa chain antibody SIC in IgG excess, IgG-anti-kappa chain antibody SIC in anti-kappa chain antibody excess, and IgG-anti-gamma chain antibody SIC in IgG excess. Three types of IgA SIC had a marked suppressive effect on neutrophil chemotaxis, while IgG SIC, free IgA, free anti-kappa chain antibody, and free anti-gamma chain antibody showed no inhibitory activity. This suppressive effect on neutrophil chemotaxis caused specifically by polymerized IgA was a cell-directed one and was expressed in a concentration dependent manner.

Document emailed within 1 workday
Secure & encrypted payments

Hasçelik, G.; Sener, B.; Hasçelik, Z. 1994: Effect of some anti-inflammatory drugs on human neutrophil chemotaxis Journal of International Medical Research 22(2): 100-106
Bubenik, O.; Meakins, J.L. 1976: Neutrophil chemotaxis in surgical patients: effect of cardiopulmonary bypass Surgical Forum 27(62): 267-269
Le Moli, S.; Seminara, R.; D'Amelio, R.; Pontesilli, O.; Nisini, R. 1983: In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing Bollettino dell'Istituto Sieroterapico Milanese 62(6): 531-534
Ciobanu, V.; Zălaru, M. 1972: Role of soluble immune complexes in pathogenesis of some inflammatory processes Medicina Interna 24(7): 793-802
Beĭko, V.A. 1985: Effect of low-density lipoproteins on neutrophil chemotaxis in chronic ischemic heart disease patients Kardiologiia 25(5): 101-103
Shibatani, N.; Yamamoto, S.; Kubota, Y.; Tsuji, K.; Takaoka, M.; Amoh, Y.; Matsushita, M.; Shimatani, M.; Imai, Y.; Inoue, K. 2002: Neutrophil chemotaxis in bile duct-obstructed rats, and effect of internal biliary drainage Hepato-Gastroenterology 49(46): 918-923
Motie, M.; Brockmeier, S.; Potempa, L.A. 1996: Binding of model soluble immune complexes to modified C-reactive protein Journal of Immunology 156(11): 4435-4441
Muchaidze, I.A.; Dodeliia, L.F.; Khubaeva, I.V.; Dodeliia, N.I.; Bendukidze, N.G.; Kikvadze, M.V. 1989: Circulating immune complexes and neutrophil function in low-birth-weight newborn infants in the early neonatal period Pediatriia 10: 37-40
Finbloom, D.S.; Martin, J.; Gordon, R.K. 1987: Endocytosis of particulate and soluble IgG immune complexes: differential effects of cytoskeletal modulating agents Clinical and Experimental Immunology 67(1): 205-210
Anderson, R.; Oosthuizen, R.; Theron, A.; Van Rensburg, A.J. 1979: The in vitro evaluation of certain neutrophil and lymphocyte functions following the ingestion of 150 mg oral dose of levamisole: assessment of the extent and duration of stimulation of neutrophil chemotaxis, protein iodination and lymphocyte transformation Clinical and Experimental Immunology 35(3): 478-483
Osipov, S.G.; Turlubekov, K.K.; Titov, V.N.; Rudnev, V.I.; Shkhvatsabaia, I.K. 1983: Suppression of thrombocyte aggregation by immune complexes. II. the effect of preformed immune complexes on thrombocyte aggregation Biulleten' Eksperimental'noi Biologii i Meditsiny 95(2): 21-23
Gleicher, N.; Adelsberg, B.R.; Liu, T.L.; Cederqvist, L.L.; Phillips, R.N.; Siegel, I. 1982: Immune complexes in pregnancy. III. Immune complexes in immune complex-associated conditions American Journal of Obstetrics and Gynecology 142(8): 1011-1015
Kilpatrick, J.M.; Virella, G. 1980: Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus Clinical and Experimental Immunology 40(3): 445-452
Konstantinova, N.A.; Lavrent'ev, V.V.; Pobedinskaia, L.K. 1986: Determining the concentration and molecular mass of circulating immune complexes. II. Determining the characteristics of immune complexes in the sera of patients and healthy persons Laboratornoe Delo 8: 487-490
Todd, G.; Dowdle, E.B. 1979: Biochemical aspects of neutrophil chemotaxis South African Medical Journal 56(22): 964-969
Elferink, J.G.; de Koster, B.M.; Boonen, G.J.; de Priester, W. 1992: Inhibition of neutrophil chemotaxis by purinoceptor agonists Archives Internationales de Pharmacodynamie et de Therapie 317: 93-106
Skripkin, I.K.; Lezvinskaia, E.M. 1986: Neutrophil chemotaxis and its role in the pathogenesis of dermatoses Vestnik Dermatologii i Venerologii 6: 31-37
Davis, J.M.; Dineen, P.; Gallin, J.I. 1980: Neutrophil degranulation and abnormal chemotaxis after thermal injury Journal of Immunology 124(3): 1467-1471
Birdsall, H.H.; Rossen, R.D. 1983: Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin Clinical and Experimental Immunology 53(2): 497-504
Rowand, J.K.; Marucha, P.; Berliner, L.J. 1992: Hirudin C-terminal fragments inhibit thrombin induced neutrophil chemotaxis Thrombosis and Haemostasis 67(3): 289-291